Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
2 Turner Place, Piscataway, NJ, USA
Strengthens and diversifies its cell therapy portfolio.
By: Charlie Sternberg
Aims to address formulation, drug persistence, and delivery challenges by enabling sustained release and enhanced solubility.
By: Kristin Brooks
Paul Josephs of Lifecore Biomedical shares insight on the injectable fill/finish space, its evolution, key trends, and challenges clients face in today’s market.
gChem’s Rishi Pimentel on pharma-grade solvents, regulatory-ready excipients, and the power behind Procipient®.
Released By gChem
How Piramal Pharma is shaping resilient, patient-centric development across OSDs, HPAPIs, and sterile injectables.
Released By Piramal Pharma Solutions
Data management, study design, and the groundwork needed to build pharma’s digital revolution.
Navigating the shift to next-generation propellants in pMDIs by balancing environmental goals, patient care, and regulatory demands.
Nasal drug delivery is now emerging as a promising route for the rapid delivery of certain classes of molecules.
Released By Upperton
Make sure to add Upperton at Stand #5.0B48 to your agenda.
CPHI Frankfurt 2025 takes place from October 28-30, 2025.
This presentation on November 4th will highlight emerging research and formulation strategies that expand the use of lipid excipients in oral tablet development.
Released By Gattefossé USA
Emerging research and formulation strategies that expand the use of lipid excipients in oral tablet development.
Transaction includes development partnership with a leading South Korean pharmaceutical company worth up to $300 million.
Expands and diversifies its drug delivery technology offerings to the biopharma industry.
The funding will support the development of OX390, an intranasal rescue medication for adulterated opioid overdoses.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
